137 related articles for article (PubMed ID: 10502359)
1. Synthesis and evaluation of two technetium-99m-labeled peptidic 2-nitroimidazoles for imaging hypoxia.
Su ZF; Zhang X; Ballinger JR; Rauth AM; Pollak A; Thornback JR
Bioconjug Chem; 1999; 10(5):897-904. PubMed ID: 10502359
[TBL] [Abstract][Full Text] [Related]
2. Targeting hypoxia in tumors using 2-nitroimidazoles with peptidic chelators for technetium-99m: effect of lipophilicity.
Zhang X; Su ZF; Ballinger JR; Rauth AM; Pollak A; Thornback JR
Bioconjug Chem; 2000; 11(3):401-7. PubMed ID: 10821657
[TBL] [Abstract][Full Text] [Related]
3. A novel amine-dioxime chelator for technetium-99m: synthesis and evaluation of 2-nitroimidazole-containing analogues as markers for hypoxic cells.
Su ZF; Ballinger JR; Rauth AM; Abrams DN; Billinghurst MW
Bioconjug Chem; 2000; 11(5):652-63. PubMed ID: 10995208
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of [
Ruan Q; Zhang X; Gan Q; Fang S; Zhang J
Bioorg Med Chem Lett; 2020 Nov; 30(22):127582. PubMed ID: 33002601
[TBL] [Abstract][Full Text] [Related]
5. TcO(PnA.O-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction.
Linder KE; Chan YW; Cyr JE; Malley MF; Nowotnik DP; Nunn AD
J Med Chem; 1994 Jan; 37(1):9-17. PubMed ID: 8289205
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and bioevaluation of the cyclopentadienyl tricarbonyl technetium-99m 2-nitroimidazole derivatives for tumor hypoxia imaging.
Su H; Chu T
Bioorg Med Chem Lett; 2022 Mar; 60():128583. PubMed ID: 35085720
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent.
Giglio J; Dematteis S; Fernández S; Cerecetto H; Rey A
J Labelled Comp Radiopharm; 2014 May; 57(6):403-9. PubMed ID: 24692093
[TBL] [Abstract][Full Text] [Related]
8. Kit formulation for preparation and biological evaluation of a novel (99m)Tc-oxo complex with metronidazole xanthate for imaging tumor hypoxia.
Li Z; Lin X; Zhang J; Wang X; Jin Z; Zhang W; Zhang Y
Nucl Med Biol; 2016 Feb; 43(2):165-70. PubMed ID: 26872441
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of the four isomers of technetium-99m labeled ethylenecysteamine cysteine ((99m)Tc-ECC), the mono-acid derivative of (99m)tc-L,L-ethylenedicysteine.
Vanbilloen HP; Cleynhens BJ; Verbruggen AM
Nucl Med Biol; 2000 Feb; 27(2):207-14. PubMed ID: 10773551
[TBL] [Abstract][Full Text] [Related]
10. Preparation and bioevaluation of a novel
Li S; Chu T
Bioorg Med Chem Lett; 2024 Jul; 106():129773. PubMed ID: 38677561
[TBL] [Abstract][Full Text] [Related]
11.
Lin X; Ruan Q; Zhang X; Duan X; Teng Y; Zhang J
Appl Radiat Isot; 2018 Oct; 140():289-293. PubMed ID: 30092554
[TBL] [Abstract][Full Text] [Related]
12. Effect of a second nitroimidazole redox centre on the accumulation of a hypoxia marker: synthesis and in vitro evaluation of 99mTc-labeled bisnitroimidazole propylene amine oxime complexes.
Huang H; Zhou H; Li Z; Wang X; Chu T
Bioorg Med Chem Lett; 2012 Jan; 22(1):172-7. PubMed ID: 22153341
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of the (99m)tc-complexes of L-cysteine acetyldiglycine (a hybrid of MAG3 and L,L-EC) and of L-beta-homocysteine acetyldiglycine.
Mang'era K; Vanbilloen H; Cleynhens B; de Groot T ; Bormans G; Verbruggen A; Verbeke K
Nucl Med Biol; 2000 Nov; 27(8):781-9. PubMed ID: 11150711
[TBL] [Abstract][Full Text] [Related]
14. Rhenium(V) and Technetium(V) Oxo Complexes of an N(2)N'S Peptidic Chelator: Evidence of Interconversion between the Syn and Anti Conformations.
Wong E; Fauconnier T; Bennett S; Valliant J; Nguyen T; Lau F; Lu LF; Pollak A; Bell RA; Thornback JR
Inorg Chem; 1997 Dec; 36(25):5799-5808. PubMed ID: 11670202
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of technetium-99m-labeled propylene amine oxime complexes containing nitroimidazole and nitrotriazole groups as hypoxia markers.
Zhang Q; Huang H; Chu T
J Labelled Comp Radiopharm; 2016 Jan; 59(1):14-23. PubMed ID: 26690916
[TBL] [Abstract][Full Text] [Related]
16. Modulation of in vivo distribution through chelator: Synthesis and evaluation of a 2-nitroimidazole-dipicolylamine-(99m)Tc(CO)3 complex for detecting tumor hypoxia.
Mallia MB; Mittal S; Sarma HD; Banerjee S
Bioorg Med Chem Lett; 2016 Jan; 26(1):46-50. PubMed ID: 26615889
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of a novel (99m)Tc-labeled bioreductive probe for tumor hypoxia imaging.
Kimura S; Umeda IO; Moriyama N; Fujii H
Bioorg Med Chem Lett; 2011 Dec; 21(24):7359-62. PubMed ID: 22078213
[TBL] [Abstract][Full Text] [Related]
18. Modifying the in vitro accumulation of BMS181321, a technetium-99m-nitroimidazole, with unlabelled nitroaromatics.
Melo T; Hua HA; Ballinger JR; Rauth AM
Biochem Pharmacol; 1997 Sep; 54(6):685-93. PubMed ID: 9310345
[TBL] [Abstract][Full Text] [Related]
19. Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41.
Welling MM; Visentin R; Feitsma HI; Lupetti A; Pauwels EK; Nibbering PH
Nucl Med Biol; 2004 May; 31(4):503-9. PubMed ID: 15093821
[TBL] [Abstract][Full Text] [Related]
20. A CD(4)/T(4) receptor peptide ligand labeled with technetium-99m: synthesis and biological activity.
Boschi A; Uccelli L; Bolzati C; Marastoni M; Tomatis R; Spisani S; Traniello S; Piffanelli A
Nucl Med Biol; 2000 Nov; 27(8):791-5. PubMed ID: 11150712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
